AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17525777 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid group (Groups III and IV)
Number of subjects: 60
Study 12571487 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with organic pathology
Number of subjects: 138
Study 12571487 — intervention group
Group type: COMPARATOR
Intervention: Patients without organic pathology
Number of subjects: 138
Study 11141929 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy
Number of subjects: 40
Study 11141929 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic therapy (Control)
Number of subjects: 40
Study 8789903 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 445
Study 8789903 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 445
Study 1281960 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish version of the Positive and Negative Syndrome Scale (PANSS)
Number of subjects: 88
Study 6242150 — intervention group
Group type: EXPERIMENTAL
Intervention: HB vaccine (5 micrograms, 3 injections at one-month intervals plus a booster after one year)
Number of subjects: 309
Study 6242150 — intervention group
Group type: EXPERIMENTAL
Intervention: HB vaccine (5 micrograms, 2 doses given at intervals of 2 or 6 months plus a booster after one year)
Number of subjects: 309
Study 6242150 — intervention group
Group type: EXPERIMENTAL
Intervention: HB vaccine
Number of subjects: 309
Study 6242150 — intervention group
Group type: COMPARATOR
Intervention: HB vaccine and DT-polio vaccine administered simultaneously
Number of subjects: 309
Study 31326975 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation combined with fiberoptic bronchoalveolar lavage
Number of subjects: 81
Study 27659296 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable membrane (RES)
Number of subjects: 27
Study 27659296 — intervention group
Group type: COMPARATOR
Intervention: Titanium-reinforced non-resorbable membrane (N-RES)
Number of subjects: 27
Study 25822479 — intervention group
Group type: EXPERIMENTAL
Intervention: Perospirone or aripiprazole
Number of subjects: 100
Study 22822181 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercise in a chest-high pool
Number of subjects: 40
Study 22822181 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 40
Study 22146169 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglactin (vicryl) mesh
Number of subjects: 150
Study 22146169 — intervention group
Group type: COMPARATOR
Intervention: Polypropylene mesh
Number of subjects: 150
Study 19249739 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated training
Number of subjects: 34
Study 19249739 — intervention group
Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 34
Study 16479196 — intervention group
Group type: EXPERIMENTAL
Intervention: Native Escherichia coli L‐asparaginase (Crasnitin; n = 10)
Number of subjects: 20
Study 16479196 — intervention group
Group type: COMPARATOR
Intervention: L‐asparaginase derived from Erwinia chrysanthemi (Erwinase; n = 10)
Number of subjects: 20
Study 14739798 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical attire
Number of subjects: 60
Study 14739798 — intervention group
Group type: COMPARATOR
Intervention: Antichemical protective gear
Number of subjects: 60
Study 11314565 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Training (PT; n = 30)
Number of subjects: 78
Study 11314565 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Counseling and Support (PCO&S; n = 28)
Number of subjects: 78
Study 11314565 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (n = 20)
Number of subjects: 78
Study 9422294 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane discontinued first (Group 1)
Number of subjects: 20
Study 9422294 — intervention group
Group type: COMPARATOR
Intervention: Nitrous oxide discontinued first (Group 2)
Number of subjects: 20
Study 9422294 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 8368679 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (CI)
Number of subjects: 81
Study 8368679 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine aspartate (AA)
Number of subjects: 81
Study 8368679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornithine alpha-ketoglutarate (OKG)
Number of subjects: 81
Study 8368679 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproheptadine (Cp)
Number of subjects: 81
Study 8368679 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 3954392 — intervention group
Group type: EXPERIMENTAL
Intervention: 10(6) IU of IFN
Number of subjects: 237
Study 3954392 — intervention group
Group type: EXPERIMENTAL
Intervention: 10(5) IU of IFN
Number of subjects: 237
Study 3954392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study 3954392 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon administration
Number of subjects: 237
Study 3954392 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment discontinuation due to adverse reactions
Number of subjects: 237
Study 31515201 — intervention group
Group type: EXPERIMENTAL
Intervention: IVC ligation
Number of subjects: 443
Study 29219480 — intervention group
Group type: EXPERIMENTAL
Intervention: Projective measurements (PMs)
Number of subjects: 0
Study 29219480 — intervention group
Group type: EXPERIMENTAL
Intervention: General measurements in dimension two or three
Number of subjects: 0
Study 29219480 — intervention group
Group type: EXPERIMENTAL
Intervention: Projective measurements
Number of subjects: 0
Study 29219480 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-qubit Werner states
Number of subjects: 0
Study 29219480 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurements
Number of subjects: 0
Study 26000551 — intervention group
Group type: EXPERIMENTAL
Intervention: Black cohosh
Number of subjects: 48
Study 26000551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 23163735 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Life style Intervention (ILI)
Number of subjects: 60
Study 23163735 — intervention group
Group type: COMPARATOR
Intervention: Conventional obesity therapy (COT)
Number of subjects: 60
Study 21756014 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared medical appointments (SMA)
Number of subjects: 103
Study 21756014 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 103
Study 17964674 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral endothelial dysfunction
Number of subjects: 0
Study 17162836 — intervention group
Group type: EXPERIMENTAL
Intervention: Unannounced visits to primary schools and health clinics
Number of subjects: 0
Study 15625442 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral feeding within 24 hours of injury
Number of subjects: 0
Study 15625442 — intervention group
Group type: COMPARATOR
Intervention: Late enteral feeding after 7 days of injury
Number of subjects: 0
Study 10768275 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (ACE inhibitor)
Number of subjects: 696
Study 10768275 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 696
Study 9389821 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic tubal catheterization
Number of subjects: 43
Study 9389821 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgical repair
Number of subjects: 43
Study 9389821 — intervention group
Group type: COMPARATOR
Intervention: Reversal of elective sterilization
Number of subjects: 43
Study 9389821 — intervention group
Group type: EXPERIMENTAL
Intervention: Both cornual-isthmic blockage-treated groups
Number of subjects: 43
Study 7951480 — intervention group
Group type: EXPERIMENTAL
Intervention: Bombesin infusion
Number of subjects: 18
Study 7951480 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 18
Study 3311923 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (160 mg/day)
Number of subjects: 33
Study 3311923 — intervention group
Group type: COMPARATOR
Intervention: Megestrol acetate/tamoxifen (20 mg/day)
Number of subjects: 33
Study 29763612 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment
Number of subjects: 60
Study 28481169 — intervention group
Group type: EXPERIMENTAL
Intervention: desipramine/naltrexone
Number of subjects: 88
Study 28481169 — intervention group
Group type: COMPARATOR
Intervention: desipramine/placebo
Number of subjects: 88
Study 28481169 — intervention group
Group type: EXPERIMENTAL
Intervention: paroxetine/naltrexone
Number of subjects: 88
Study 28481169 — intervention group
Group type: COMPARATOR
Intervention: paroxetine/placebo
Number of subjects: 88
Study 26148327 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led psychoeducational intervention (brief or extensive)
Number of subjects: 484
Study 26148327 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 484
Study 24284856 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal VALE-ibuprofen (200 mg ibuprofen, 2.0 grams of drug product applied twice daily for 14 days)
Number of subjects: 64
Study 24284856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 24284856 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal VALE-ibuprofen
Number of subjects: 64
Study 20955821 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized active-maintenance intervention over 48 months
Number of subjects: 1277
Study 20955821 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1277
Study 18317064 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL)
Number of subjects: 382
Study 18317064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 382
Study 16126290 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal oxygen (4 L/min)
Number of subjects: 11
Study 16126290 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) (mean 9.3 cm H(2)O)
Number of subjects: 11
Study 16126290 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure (BiPAP) (mean 12.0/5.3 cm H(2)O)
Number of subjects: 11
Study 16126290 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency jet ventilation (HFJV) (60-80 breaths per minute)
Number of subjects: 11
Study 16126290 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 11
Study 14571151 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (paroxetine)
Number of subjects: 150
Study 14571151 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin-noradrenaline reuptake inhibitor (venlafaxine)
Number of subjects: 150
Study 14571151 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (absence of previous therapies, moderate baseline severity of obsessive-compulsive symptoms, low Hamilton Depressive Rating Scale scores)
Number of subjects: 150
Study 14571151 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 150
Study 11056332 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg once daily
Number of subjects: 668
Study 11056332 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen 20 mg daily
Number of subjects: 668
Study 7740933 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal adjustment
Number of subjects: 50
Study 7740933 — intervention group
Group type: COMPARATOR
Intervention: Comfort only (Control)
Number of subjects: 50
Study 1982059 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg/day)
Number of subjects: 10
Study 1982059 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol (80 mg/day)
Number of subjects: 10
Study 1982059 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/day)
Number of subjects: 10
Study 1982059 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol (200 mg/day)
Number of subjects: 10
Study 1982059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 233458 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural administration of Corynebacterium parvum (7 mg)
Number of subjects: 475
Study 233458 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 475
Study 233458 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 475
Study 31977632 — intervention group
Group type: COMPARATOR
Intervention: no-exercise control (n = 42)
Number of subjects: 163
Study 31977632 — intervention group
Group type: EXPERIMENTAL
Intervention: low-amount, low-intensity exercise (LALI; n = 39)
Number of subjects: 163
Study 31977632 — intervention group
Group type: EXPERIMENTAL
Intervention: high-amount, low-intensity exercise (HALI; n = 51)
Number of subjects: 163
Study 31977632 — intervention group
Group type: EXPERIMENTAL
Intervention: high-amount, high-intensity exercise (HAHI; n = 31)
Number of subjects: 163
Study 30309816 — intervention group
Group type: EXPERIMENTAL
Intervention: Rufinamide (≤45 mg/kg/day)
Number of subjects: 37
Study 30309816 — intervention group
Group type: COMPARATOR
Intervention: Any other AED
Number of subjects: 37
Study 28802307 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-fat, higher-carbohydrate diet (20% fat, 66% carbohydrate, 14% protein)
Number of subjects: 300
Study 28802307 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-fat, moderate-carbohydrate diet (30% fat, 56% carbohydrate, 14% protein)
Number of subjects: 300
Study 28802307 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-fat, lower-carbohydrate diet (40% fat, 46% carbohydrate, 14% protein)
Number of subjects: 300
Study 26660938 — intervention group
Group type: EXPERIMENTAL
Intervention: Visomitin eye drops, self-administered three times daily (TID) for 6 weeks
Number of subjects: 240
Study 26660938 — intervention group
Group type: COMPARATOR
Intervention: Placebo, self-administered three times daily (TID) for 6 weeks
Number of subjects: 240
Study 26660938 — intervention group
Group type: EXPERIMENTAL
Intervention: Visomitin eye drops
Number of subjects: 240
Study 23260618 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (30 min daily for 7 days)
Number of subjects: 60
Study 23260618 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 60
Study 21189270 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin (45mg/kg/day for 3 days)
Number of subjects: 900
Study 21189270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study 18650545 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg/day for 4 days
Number of subjects: 36
Study 18650545 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 days
Number of subjects: 36
Study 17143127 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention-physical exercise program
Number of subjects: 75
Study 17143127 — intervention group
Group type: COMPARATOR
Intervention: Nutritional intervention program
Number of subjects: 75
Study 12625081 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral decubitus 'biopsy‐side‐down' position
Number of subjects: 87
Study 12625081 — intervention group
Group type: COMPARATOR
Intervention: Biopsy‐site‐dependent position (lying directly on the skin puncture site)
Number of subjects: 87
Study 10845809 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 1 + 8 schedule (5FU and CTX 500mg/m2 day 1, epirubicin 40 mg/m2 day 1 and 8)
Number of subjects: 104
Study 10845809 — intervention group
Group type: COMPARATOR
Intervention: Day 1 schedule (5FU, CTX 500 mg/m2 and epirubicin 80 mg/m2 day 1)
Number of subjects: 104
Study 9209791 — intervention group
Group type: EXPERIMENTAL
Intervention: MLD/PD-heterozygotes
Number of subjects: 3
Study 9209791 — intervention group
Group type: EXPERIMENTAL
Intervention: MLD-patients
Number of subjects: 3
Study 9209791 — intervention group
Group type: COMPARATOR
Intervention: PD/PD-homozygotes
Number of subjects: 3
Study 8271802 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment focused on drinking reduction techniques
Number of subjects: 0
Study 2961316 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular chloroquine (10 mg base kg‐1)
Number of subjects: 619
Study 2961316 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated chloroquine (10 mg base kg‐1)
Number of subjects: 619
Study 2961316 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine (10 mg base kg‐1)
Number of subjects: 619
Study 2961316 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated ferrous sulphate (300 mg tablet)
Number of subjects: 619
Study 30029600 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental nudges such as food product placement or promotion
Number of subjects: 1000
Study 30029600 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudges and a tailored physical activity app that provides time- and context-specific feedback
Number of subjects: 1000
Study 30029600 — intervention group
Group type: EXPERIMENTAL
Intervention: Pricing interventions, nudges, and the physical activity app
Number of subjects: 1000
Study 30029600 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 1000
Study 30029600 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions combined
Number of subjects: 1000
Study 26686313 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg oral daily for 5 years)
Number of subjects: 2980
Study 26686313 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (20 mg oral daily for 5 years)
Number of subjects: 2980
Study 26686313 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 2980
Study 26686313 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 2980
Study 24927611 — intervention group
Group type: COMPARATOR
Intervention: sTNF‐R1 levels in patients with IGT and DM
Number of subjects: 54
Study 24927611 — intervention group
Group type: COMPARATOR
Intervention: TGF‐β1 levels in patients with IGT and DM
Number of subjects: 54
Study 24927611 — intervention group
Group type: COMPARATOR
Intervention: Leptin, HGF, and TNF‐α levels
Number of subjects: 54
Study 24927611 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine levels in Child‐Pugh classification groups B or C
Number of subjects: 54
Study 24927611 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlations between sTNF‐R1 and HOMA2‐IR
Number of subjects: 54
Study 24927611 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlations between leptin and HOMA2‐IR
Number of subjects: 54
Study 22880214 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC) - four 5 min cycles of transient upper limb ischaemia/reperfusion
Number of subjects: 2070
Study 22880214 — intervention group
Group type: COMPARATOR
Intervention: Control group - four cycles of blood pressure cuff inflation/deflation at a dummy arm
Number of subjects: 2070
Study 20359355 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive functions assessed using the Trail Making Test (Part B)
Number of subjects: 0
Study 20359355 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive functions assessed using the Digits Verbal Span Backward Test
Number of subjects: 0
Study 20359355 — intervention group
Group type: EXPERIMENTAL
Intervention: Global cognition assessed using the Mini-Mental State Examination (MMSE)
Number of subjects: 0
Study 20359355 — intervention group
Group type: COMPARATOR
Intervention: Resistance training (not detailed in the abstract)
Number of subjects: 0
Study 18787198 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile teleconsultation
Number of subjects: 223
Study 18787198 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based teleconsultation
Number of subjects: 223
Study 15917033 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun Protection is Fun! (S.P.F.) intervention including a video, newsletters, and handbooks
Number of subjects: 384
Study 12873112 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified pen grip
Number of subjects: 0
Study 12873112 — intervention group
Group type: COMPARATOR
Intervention: Non-pen grip
Number of subjects: 0
Study 10574478 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula supplemented with arginine, omega-3 fatty acids, and RNA (verum group)
Number of subjects: 50
Study 10574478 — intervention group
Group type: COMPARATOR
Intervention: Control enteral formula (control group)
Number of subjects: 50
Study 8923091 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-gamma (Imukin)
Number of subjects: 0
Study 8923091 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 1426657 — intervention group
Group type: EXPERIMENTAL
Intervention: IMOCURR
Number of subjects: 423
Study 1426657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 423
Study 4047104 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined estrogen‐progestogen (high-dose: 4 mg of estradiol)
Number of subjects: 136
Study 4047104 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined estrogen‐progestogen (other doses)
Number of subjects: 136
Study 4047104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 4047104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 136
Study 29552762 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon nanoparticle tracer for intraoperative dye detection and positioning
Number of subjects: 80
Study 29552762 — intervention group
Group type: COMPARATOR
Intervention: Surgery (control group)
Number of subjects: 80
Study 27532508 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone Marrow (BM) transplantation
Number of subjects: 551
Study 27532508 — intervention group
Group type: COMPARATOR
Intervention: Peripheral Blood (PB) transplantation
Number of subjects: 551
Study 24408441 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress group (SG)
Number of subjects: 0
Study 24408441 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 22543889 — intervention group
Group type: EXPERIMENTAL
Intervention: Kicking and treadmill stepping intervention
Number of subjects: 16
Study 22543889 — intervention group
Group type: COMPARATOR
Intervention: No-training control condition
Number of subjects: 16
Study 20540639 — intervention group
Group type: EXPERIMENTAL
Intervention: Keto acids‐supplemented low‐protein diet (sLP: 0.6‐0.8 g/kg IBW/d + 0.12 g/kg IBW/d of keto acids, n = 12)
Number of subjects: 39